Table 1.
PATIENT ID | PRIMARY DIAGNOSIS | CLINICAL STAGE | GENDER | RACE | AGE |
---|---|---|---|---|---|
NSCLC adenocarcinoma | |||||
1 | NSCLC adenocarcinoma | IV | F | Caucasian | 43 |
2 | NSCLC adenocarcinoma | IV | F | Caucasian | 62 |
3 | NSCLC adenocarcinoma | IV | F | Caucasian | 63 |
4 | NSCLC adenocarcinoma | IV | M | Caucasian | 74 |
5 | NSCLC adenocarcinoma | IV | F | Caucasian | 51 |
6 | NSCLC adenocarcinoma | IV | M | Caucasian | 68 |
7 | NSCLC adenocarcinoma | III-B | M | Caucasian | 51 |
8 | NSCLC adenocarcinoma | IV | F | Caucasian | 65 |
9 | NSCLC adenocarcinoma | III-B | M | Caucasian | 88 |
10 | NSCLC adenocarcinoma | IV | F | Caucasian | 65 |
11 | NSCLC adenocarcinoma | IV | M | Caucasian | 64 |
12 | NSCLC adenocarcinoma | IV | F | Caucasian | 73 |
13 | NSCLC adenocarcinoma | IV | F | Caucasian | 77 |
14 | NSCLC adenocarcinoma | IV | F | Caucasian | 70 |
PATIENT ID | PRIMARY DIAGNOSIS | CLINICAL STAGE | GENDER | RACE | AGE | HER2 | ER | PR |
---|---|---|---|---|---|---|---|---|
Breast cancer | ||||||||
1 | Breast cancer | IV | F | Caucasian | 70 | − | + | − |
2 | Breast cancer | III | F | African American | 48 | − | − | − |
3 | Breast cancer | III | F | Caucasian | 47 | − | + | + |
4 | Breast cancer | III | F | Caucasian | 76 | − | + | + |
5 | Breast cancer | III | F | Caucasian | 72 | − | − | − |
6 | Breast cancer | IV | F | Caucasian | 62 | − | − | − |
7 | Breast cancer | III | F | African American | 42 | − | + | + |
8 | Breast cancer | III | F | Caucasian | 77 | − | + | + |
9 | Breast cancer | III | F | Caucasian | 44 | − | + | + |
10 | Breast cancer | III | F | African American | 62 | − | + | + |
11 | Breast cancer | IV | F | African American | 54 | − | − | − |
12 | Breast cancer | III | F | African American | 57 | − | + | + |
13 | Breast cancer | III | F | Caucasian | 60 | − | + | + |
14 | Breast cancer | III | F | African American | 38 | − | − | − |
15 | Breast cancer | IV | F | African American | 33 | − | − | − |
16 | Breast cancer | III | F | African American | 66 | − | + | + |
17 | Breast cancer | IV | F | Caucasian | 68 | − | + | − |
18 | Breast cancer | IV | F | Caucasian | 55 | − | + | − |
19 | Breast cancer | III | F | African American | 64 | − | + | + |
20 | Breast cancer | III | F | Caucasian | 50 | − | + | + |
PATIENT ID | PRIMARY DIAGNOSIS | CLINICAL STAGE | GENDER | RACE | AGE |
---|---|---|---|---|---|
Ovarian | |||||
1 | Ovarian cancer, papillary serous | IV | F | Caucasian | 48 |
2 | Ovarian cancer, papillary serous | IV | F | Caucasian | 75 |
3 | Ovarian cancer, papillary serous | IV | F | Caucasian | 55 |
4 | Ovarian cancer, papillary serous | IV | F | Caucasian | 70 |
5 | Ovarian cancer, papillary serous | IV | F | Caucasian | 43 |
6 | Ovarian cancer, papillary serous | IV | F | Caucasian | 69 |
PATIENT ID | PRIMARY DIAGNOSIS | CLINICAL STAGE | GENDER | RACE | AGE |
---|---|---|---|---|---|
NSCLC squamous | |||||
1 | NSCLC squamous cell carcinoma’ | IV | F | Caucasian | 56 |
2 | NSCLC squamous cell carcinoma’ | IV | F | Caucasian | 66 |
3 | NSCLC squamous cell carcinoma’ | IV | F | Caucasian | 66 |
4 | NSCLC squamous cell carcinoma’ | IV | F | African American | 56 |
5 | NSCLC squamous cell carcinoma’ | IV | F | Caucasian | 73 |
6 | NSCLC squamous cell carcinoma’ | IV | F | White | 73 |